Omeros Corp. buy tamam
Start price
21.12.17
/
50%
€17.58
Target price
01.01.19
€29.77
Performance (%)
-42.84%
End price
01.01.19
€10.05
Summary
This prediction ended on 01.01.19 with a price of €10.05. The BUY prediction by tamam for Omeros Corp. performed very badly with a performance of -42.84%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Omeros Corp. | -4.850% | -4.850% | 148.193% | 18.221% |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% | 48.430% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% | 84.278% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% | 59.283% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% | 62.512% |
Comments by tamam for this prediction
In the thread Omeros Corp. diskutieren
tamam stimmt der Buy-Einschätzung von marge zu
tamam stimmt am 21.12.2017 der Buy-Einschätzung von marge, aber mit dem Kursziel 33$ zu.
Überschrift: Orphan drug market support blockbuster potential for OMS721
(Laufzeit überschritten)